Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

10.63 -0.07 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Anika Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in Upcoming Investor Conferences
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Enters Into Cooperation Agreement with Caligan Partners
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Files Preliminary Proxy Statement
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Issues Statement
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
From Anika Therapeutics Inc.
Via GlobeNewswire
News headline image
Sidoti's Summer Small Cap Virtual Conference
NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and... 
From Sidoti & Company, LLC
Via AccessWire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.